No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
VRTX241227C390000
- 18.00
- +1.50+9.09%
15min DelayClose Dec 24 13:00 ET
18.00High18.00Low
18.00Open16.50Pre Close10 Volume13 Open Interest390.00Strike Price18.00KTurnover0.00%IV-0.04%PremiumDec 27, 2024Expiry Date18.18Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma23.19Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?
Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know
Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals
Vertex Pharmaceuticals Price Target Lowered to $460 From $550 at Truist
Truist has lowered the Vertex Target Price to 460 dollars.
Truist: lowered the Target Price of Vertex Pharmaceuticals from $550 to $460, maintaining a Buy rating. (Gelonghui)
A Quick Look at Today's Ratings for Vertex Pharmaceuticals(VRTX.US), With a Forecast Between $430 to $525